GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HBM Holdings Ltd (OTCPK:HBMHF) » Definitions » Equity-to-Asset

HBM Holdings (HBM Holdings) Equity-to-Asset : 0.53 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is HBM Holdings Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. HBM Holdings's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $119.99 Mil. HBM Holdings's Total Assets for the quarter that ended in Dec. 2023 was $228.48 Mil. Therefore, HBM Holdings's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.53.

The historical rank and industry rank for HBM Holdings's Equity-to-Asset or its related term are showing as below:

HBMHF' s Equity-to-Asset Range Over the Past 10 Years
Min: -2.21   Med: 0.46   Max: 0.93
Current: 0.53

During the past 6 years, the highest Equity to Asset Ratio of HBM Holdings was 0.93. The lowest was -2.21. And the median was 0.46.

HBMHF's Equity-to-Asset is ranked worse than
62.04% of 1565 companies
in the Biotechnology industry
Industry Median: 0.67 vs HBMHF: 0.53

HBM Holdings Equity-to-Asset Historical Data

The historical data trend for HBM Holdings's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HBM Holdings Equity-to-Asset Chart

HBM Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial -2.21 0.93 0.79 0.40 0.53

HBM Holdings Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.79 0.59 0.40 0.45 0.53

Competitive Comparison of HBM Holdings's Equity-to-Asset

For the Biotechnology subindustry, HBM Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HBM Holdings's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HBM Holdings's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where HBM Holdings's Equity-to-Asset falls into.



HBM Holdings Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

HBM Holdings's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=119.988/228.48
=0.53

HBM Holdings's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=119.988/228.48
=0.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HBM Holdings  (OTCPK:HBMHF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


HBM Holdings Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of HBM Holdings's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


HBM Holdings (HBM Holdings) Business Description

Traded in Other Exchanges
Address
420 Fenglin Road, 12th Floor, Tower A, Fenglin International Plaza Phase II, Xuhui District, Shanghai, CHN, 200032
HBM Holdings Ltd is a clinical-stage biopharmaceutical company engaged in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. Its products under development are Batoclimab, for the treatment of a wide spectrum of autoimmune diseases; Tanfanercept, for the treatment of moderate-to-severe dry eye disease (DED); HBM4003; HBM9378, to prevent and treat COVID-19, the pandemic respiratory disease caused by the SARS-CoV-2 virus; HBM7008; and others. Its geographical segments are Mainland China, United States, Europe, and others. Majority of revenue is generated from Europe.

HBM Holdings (HBM Holdings) Headlines

From GuruFocus

Harbour BioMed Announces Positive Profit Alert

By PRNewswire 01-19-2024